Literature DB >> 23372499

SWOT Analysis for Molecular Diagnostics: Strengths, Weaknesses, Opportunities, and Threats.

Daniel H Farkas1, David W Bernard.   

Abstract

Daniel Farkas, PhD, and David Bernard, MD, PhD, discuss strengths, weaknesses, opportunities, and threats associated with molecular diagnostics.

Year:  2004        PMID： 23372499      PMCID： PMC3555168     

Source DB:  PubMed          Journal:  Biotechnol Healthc        ISSN： 1554-169X


  2 in total

1.  Effects of patents and licenses on the provision of clinical genetic testing services.

Authors:  Mildred K Cho; Samantha Illangasekare; Meredith A Weaver; Debra G B Leonard; Jon F Merz
Journal:  J Mol Diagn       Date:  2003-02       Impact factor: 5.568

2.  Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid.

Authors:  J D WATSON; F H CRICK
Journal:  Nature       Date:  1953-04-25       Impact factor: 49.962
  2 in total
  2 in total

1.  The 5 stages of biotechnology management.

Authors:  Thomas Baker
Journal:  Biotechnol Healthc       Date:  2005-02

2.  Caspofungin MIC Distribution amongst Commonly Isolated Candida Species in a Tertiary Care Centre - An Indian Experience.

Authors:  Shashir Wanjare; Rajarshi Gupta; Preeti Mehta
Journal:  J Clin Diagn Res       Date:  2016-11-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.